We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$175M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$26.7M
3
SOXX icon
iShares Semiconductor ETF
SOXX
+$12.1M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$11.3M
5
IWV icon
iShares Russell 3000 ETF
IWV
+$9.58M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMKTA icon
2601
Ingles Markets
IMKTA
$1.62B
$80K ﹤0.01%
1,382
-400
-22% -$24.8K
JYNT icon
2602
The Joint Corp
JYNT
$123M
$80K ﹤0.01%
956
+278
+41% +$17.2K
SPSC icon
2603
SPS Commerce
SPSC
$2.69B
$80K ﹤0.01%
806
-2,797
-78% -$276K
SUPN icon
2604
Supernus Pharmaceuticals
SUPN
$2.74B
$80K ﹤0.01%
2,616
-2,525
-49% -$77.4K
QUOT
2605
DELISTED
Quotient Technology Inc
QUOT
$80K ﹤0.01%
7,339
+1,485
+25% +$19.8K
SV
2606
DELISTED
Spring Valley Acquisition Corp. Class A Ordinary Share
SV
$80K ﹤0.01%
+8,048
New +$80.3K
RESN
2607
DELISTED
Resonant Inc.
RESN
$80K ﹤0.01%
25,046
-12,560
-33% -$43.1K
CNST
2608
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$80K ﹤0.01%
2,348
-1,218
-34% -$31K
ADEA icon
2609
Adeia
ADEA
$3.07B
$79K ﹤0.01%
13,468
-34,931
-72% -$199K
APO icon
2610
Apollo Global Management
APO
$76B
$79K ﹤0.01%
1,263
-40,489
-97% -$2.25M
ATRA icon
2611
Atara Biotherapeutics
ATRA
$77.6M
$79K ﹤0.01%
203
-112
-36% -$39.9K
BRT
2612
BRT Apartments
BRT
$266M
$79K ﹤0.01%
4,546
+3,179
+233% +$56.9K
CCO icon
2613
Clear Channel Outdoor Holdings
CCO
$1.23B
$79K ﹤0.01%
+29,794
New +$71.4K
CRON
2614
Cronos Group
CRON
$1.11B
$79K ﹤0.01%
9,156
+5,472
+149% +$45.3K
CWH icon
2615
Camping World
CWH
$635M
$79K ﹤0.01%
1,932
-4,559
-70% -$189K
CWST icon
2616
Casella Waste Systems
CWST
$5.72B
$79K ﹤0.01%
1,251
-4,715
-79% -$313K
GFL icon
2617
GFL Environmental
GFL
$14.9B
$79K ﹤0.01%
2,470
-2,386
-49% -$78.1K
MBIO icon
2618
Mustang Bio
MBIO
$4.47M
$79K ﹤0.01%
32
-7
-18% -$17.2K
MRSN
2619
DELISTED
Mersana Therapeutics
MRSN
$79K ﹤0.01%
233
-107
-31% -$40.5K
ODP
2620
DELISTED
ODP
ODP
$79K ﹤0.01%
1,653
-5,848
-78% -$258K
PPC icon
2621
Pilgrim's Pride
PPC
$6.31B
$79K ﹤0.01%
3,568
+58
+2% +$1.38K
CHS
2622
DELISTED
Chicos FAS, Inc.
CHS
$79K ﹤0.01%
12,034
-857
-7% -$3.69K
AHT
2623
Ashford Hospitality Trust
AHT
$20.7M
$78K ﹤0.01%
+171
New +$62K
AMRX icon
2624
Amneal Pharmaceuticals
AMRX
$5.71B
$78K ﹤0.01%
15,143
+5,184
+52% +$29.5K
ARQT icon
2625
Arcutis Biotherapeutics
ARQT
$3.26B
$78K ﹤0.01%
2,856
+1,627
+132% +$45.8K
103 104
105
106 107

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.